Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Global Medical Marijuana Market Report 2024: Market Value to Reach $154.83 Billion by 2034 from $16.88 Billion in 2023 | ||
By: PR Newswire Association LLC. - 02 Feb 2024 | Back to overview list |
|
DUBLIN, Feb. 2, 2024 /PRNewswire/ -- The "Global Medical Marijuana Market Analysis & Forecast 2024-2034: Market By Product; By Application; By End-user; and By Region" report has been added to ResearchAndMarkets.com's offering. The global medical marijuana market size was estimated to be USD 16.88 billion in 2023 and is expected to reach at USD 154.83 billion by 2034 with a CAGR of 22.32% during the forecast period 2024-2034. Growing awareness regarding various therapeutic applications of the marijuana, surge in permitting the usage of medical marijuana, increasing adoption of cannabis in therapeutic applications, rising research & development activities, growing prevalence of chronic diseases, and increase in acquisition of market players for the manufacturing of advanced medical products are some of the key factors boosting the market growth. North America region is anticipated for the highest revenue share during the forecast period owing to the surge in cannabis legalization, increasing product launches by major market players. For instance, in December 2022, Jushi Holdings Inc., a multi-state cannabis operator with vertical integration, has introduced a diverse range of products in California, featuring three distinct brands tailored to cater to the preferences and budget considerations of cannabis consumers. The company has expanded its offerings to include Seche Pre-Roll Singles, Tasteology Fruit Chews, and The Lab Vapes, presenting a fresh assortment of premium brands and unique products exclusively accessible at the Company's Beyond HelloT retail outlets in California. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing favourable government initiatives, growing disposable income, rising awareness regarding the benefits of the product, surge in the legalization of cannabis, and increasing research & development activities. Additionally, many other countries worldwide are following the lead of North America by legalizing cannabis. Therefore, the increasing trend of cannabis decriminalization is expected to significantly boost the development & launch of medical marijuana. For instance, in March 2023, Irwin Naturals Inc. is delighted to inform the public about the launch of their new product, Irwin Naturals Cannabis CBD 25mg Softgels, which are now accessible across Canada through the Starseed Medicinal Medical Group platform. For instance, In August 2023, The National Health Service (NHS) research ethics committee has granted authorization for a clinical trial on non-cancer-related chronic pain conducted by the private health clinic LVL Health. This pharmaceutical firm has dedicated its efforts to research, growing, producing, and distributing innovative cannabis-based medications. It has now received approval to commence its trial, which aims to involve as many as 5,000 patients. Additionally, amyotrophic lateral sclerosis (ALS) is predicted to grow at fastest CAGR during the forecast period owing to the increasing prevalence of amyotrophic lateral sclerosis and rising legalization of the use of cannabis. For instance, in February 2022, Leaf Trade, Inc., a wholesale marketplace for the cannabis industry serving various stakeholders such as cannabis sellers, brands, distributors, and retailers across 25 markets, has unveiled a nationwide partnership with Curaleaf Holdings, Inc., a prominent global supplier of consumer cannabis products. While Leaf Trade is currently collaborating with Curaleaf in 11 states, this national partnership will extend its support to cover Curaleaf's operations in all 19 U.S. Wholesale Markets, including the upcoming launch in New York scheduled for this month. Additionally, research & development centres is predicted to grow at fastest CAGR during the forecast period owing to the growing research & development activities, rising number of clinical trials, and surge in focus on development of novel products. Company Profiles
Segmentation: Medical Marijuana Market Report 2022 - 2033 Medical Marijuana Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
Medical Marijuana Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
Medical Marijuana Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
Medical Marijuana Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn) North America
Europe
Asia Pacific
Latin America
Middle East & Africa
For more information about this report visit https://www.researchandmarkets.com/r/o8aa8u About ResearchAndMarkets.com Media Contact: Research and Markets Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg View original content:https://www.prnewswire.com/news-releases/global-medical-marijuana-market-report-2024-market-value-to-reach-154-83-billion-by-2034-from-16-88-billion-in-2023--302051908.html SOURCE Research and Markets |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |